{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:46:30Z","timestamp":1789695990690,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T00:00:00Z","timestamp":1627171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T00:00:00Z","timestamp":1627171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To prevent ovarian cancer, several international societies have issued guidelines which recommend to discuss opportunistic salpingectomy with women undergoing pelvic surgery after completion of childbearing. The opportunistic salpingectomy refers to the additional removal of Fallopian tubes during pelvic surgery for another indication to reduce the risk of developing ovarian cancer. These recommendations emphasize the importance of counselling on benefits and risks of opportunistic salpingectomy but offer no guidance on their implementation in daily practice. The lack of a tailored implementation strategy has resulted in a wide variation in current practice. To reduce this practice variation, we identified influencing factors on implementing opportunistic salpingectomy from patients\u2019 and professionals\u2019 perspectives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a mixed-method study between 2019 and 2020 throughout the Netherlands. In a qualitative phase, we conducted interviews with gynecologic patients (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200911) and their professionals (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200920) to explore barriers and facilitators, using an interview guide. In the quantitative phase, we quantified these barriers and facilitators among patients who underwent a hysterectomy or sterilization and were counselled on the opportunistic salpingectomy (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200977), and members of the Dutch Society of Obstetrics and Gynecology (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009204), using questionnaires. For both phases, barriers and facilitators were classified into the following domains: innovation, patient, healthcare professional, social setting, organization, and economic and political context.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For patients, main barriers were lack of knowledge about: the existence of the opportunistic salpingectomy (45%), size of the surgery (44%) and its associated possible disadvantages (37%). In addition, patients attributed their reluctance to concerns about the removal of healthy organs (46%). For professionals, main barriers were: patients\u2019 lack of knowledge of the size of surgery (85%) and its associated possible disadvantages (77%), the gap in evidence on long term risks and benefits (43%), the lack of feasibility in certain patients and during vaginal surgery (66%). Both patients (41%) and professionals (67%) identified the need for counselling material as facilitator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To reduce the variety in care regarding opportunistic salpingectomy, consensus and uniform counselling is needed. Including the opportunistic salpingectomy in gynecological guidelines and a decision aid for counselling could serve as tools to facilitate implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-021-06767-9","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T19:04:24Z","timestamp":1627153464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patients\u2019 and professionals\u2019 perspectives on implementation of opportunistic salpingectomy: a mixed-method study"],"prefix":"10.1186","volume":"21","author":[{"given":"Malou E.","family":"Gelderblom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A. M.","family":"Van Lieshout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen M. J.","family":"Piek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"De Hullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella P. M. G.","family":"Hermens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,25]]},"reference":[{"issue":"4","key":"6767_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396. https:\/\/doi.org\/10.3322\/caac.21456.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"6767_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001;195(4):451\u20136. https:\/\/doi.org\/10.1002\/path.1000.","journal-title":"J Pathol"},{"issue":"2","key":"6767_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00404-013-3041-3","volume":"289","author":"J Dietl","year":"2014","unstructured":"Dietl J. Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Arch Gynecol Obstet. 2014;289(2):241\u20136. https:\/\/doi.org\/10.1007\/s00404-013-3041-3.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"6767_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1701-2163(15)30659-9","volume":"36","author":"CJ Reade","year":"2014","unstructured":"Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, et al. The fallopian tube as the origin of high grade serous ovarian Cancer: review of a paradigm shift. J Obstet Gynaecol Can. 2014;36(2):133\u201340. https:\/\/doi.org\/10.1016\/S1701-2163(15)30659-9.","journal-title":"J Obstet Gynaecol Can"},{"key":"6767_CR5","doi-asserted-by":"publisher","unstructured":"Falconer H, Yin L, Gronberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015;107(2):1\u20136. https:\/\/doi.org\/10.1093\/jnci\/dju410.","DOI":"10.1093\/jnci\/dju410"},{"issue":"1","key":"6767_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/aogs.12516","volume":"94","author":"C Madsen","year":"2015","unstructured":"Madsen C, Baandrup L, Dehlendorff C, Kjaer SK. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study. Acta Obstet Gynecol Scand. 2015;94(1):86\u201394. https:\/\/doi.org\/10.1111\/aogs.12516.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6767_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","volume":"55","author":"SH Yoon","year":"2016","unstructured":"Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta-analysis. Eur J Cancer. 2016;55:38\u201346. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.003.","journal-title":"Eur J Cancer"},{"issue":"1","key":"6767_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/humupd\/dmq030","volume":"17","author":"D Cibula","year":"2011","unstructured":"Cibula D, Widschwendter M, Majek O, Dusek L. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Hum Reprod Update. 2011;17(1):55\u201367. https:\/\/doi.org\/10.1093\/humupd\/dmq030.","journal-title":"Hum Reprod Update"},{"key":"6767_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejogrb.2018.03.043","volume":"225","author":"A Ntoumanoglou-Schuiki","year":"2018","unstructured":"Ntoumanoglou-Schuiki A, Tomasch G, Laky R, Taumberger N, Bjelic-Radisic V, Tamussino K. Opportunistic prophylactic salpingectomy for prevention of ovarian cancer: what do national societies advise? Eur J Obstet Gynecol Reprod Biol. 2018;225:110\u20132. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.03.043.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"6767_CR10","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.3802\/jgo.2019.30.e2","volume":"30","author":"MP Steenbeek","year":"2019","unstructured":"Steenbeek MP, van Lieshout LAM, Aarts JWM, Piek JMJ, Coppus S, Massuger L, et al. Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey. J Gynecol Oncol. 2019;30(1):e2. https:\/\/doi.org\/10.3802\/jgo.2019.30.e2.","journal-title":"J Gynecol Oncol"},{"key":"6767_CR11","doi-asserted-by":"publisher","unstructured":"Grol R, Wensing M, Eccles M, Davis D. Improving patient care: the implementation of change in health care. Oxford: John Wiley & Sons; 2013. https:\/\/doi.org\/10.1002\/9781118525975.","DOI":"10.1002\/9781118525975"},{"issue":"6 Pt 2","key":"6767_CR12","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/1475-6773.12117","volume":"48","author":"MD Fetters","year":"2013","unstructured":"Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48(6 Pt 2):2134\u201356. https:\/\/doi.org\/10.1111\/1475-6773.12117.","journal-title":"Health Serv Res"},{"issue":"4","key":"6767_CR13","first-page":"255","volume":"16","author":"VA Lambert","year":"2012","unstructured":"Lambert VA, Lambert CE. Qualitative descriptive research: an acceptable design. Pac Rim Int J Nurs Res. 2012;16(4):255\u20136.","journal-title":"Pac Rim Int J Nurs Res"},{"issue":"4","key":"6767_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/09540269874619","volume":"10","author":"M Prince","year":"1998","unstructured":"Prince M. The cross-sectional survey. Int Rev Psychiatry. 1998;10(4):272\u20137. https:\/\/doi.org\/10.1080\/09540269874619.","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"6767_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1258\/jhsrp.2007.007074","volume":"13","author":"A O'Cathain","year":"2008","unstructured":"O'Cathain A, Murphy E, Nicholl J. The quality of mixed methods studies in health services research. J Health Serv Res Policy. 2008;13(2):92\u20138. https:\/\/doi.org\/10.1258\/jhsrp.2007.007074.","journal-title":"J Health Serv Res Policy"},{"issue":"19","key":"6767_CR16","first-page":"340","volume":"6","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbur YP, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checkllist for interviews and focus groups. Int J Qual Health Care. 2007;6(19):340\u201357.","journal-title":"Int J Qual Health Care"},{"key":"6767_CR17","doi-asserted-by":"crossref","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS, et al. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;9:1\u20139.","DOI":"10.1007\/s11606-021-06737-1"},{"issue":"S6","key":"6767_CR18","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.5694\/j.1326-5377.2004.tb05948.x","volume":"180","author":"R Grol","year":"2004","unstructured":"Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust. 2004;180(S6):S57\u201360. https:\/\/doi.org\/10.5694\/j.1326-5377.2004.tb05948.x.","journal-title":"Med J Aust"},{"key":"6767_CR19","doi-asserted-by":"crossref","unstructured":"Flottorp SA, Oxman AD, Krause J, Musila NR, Wensing M, Godycki-Cwirko M, et al. A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implementation Sci. 2013;8(1).","DOI":"10.1186\/1748-5908-8-35"},{"key":"6767_CR20","volume-title":"Limesurvey [computer software]","author":"C Schmitz","year":"2010","unstructured":"Schmitz C. Limesurvey [computer software]; 2010."},{"key":"6767_CR21","unstructured":"Gliem JA, Gliem RR. Calculating, Interpreting, and Reporting Crohnbach\u2019s Alpha Reliability Coefficient for Likert-Type Scales Midwest Research-to-Practice Conference in Adult, Continuing, and Community Education. 2003."},{"issue":"5","key":"6767_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s11606-007-0149-9","volume":"22","author":"L Fraenkel","year":"2007","unstructured":"Fraenkel L, McGraw S. What are the essential elements to enable patient participation in medical decision making? J Gen Intern Med. 2007;22(5):614\u20139. https:\/\/doi.org\/10.1007\/s11606-007-0149-9.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"6767_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ygyno.2017.05.039","volume":"146","author":"Group PEsOOG","year":"2017","unstructured":"Group PEsOOG. A systematic review of patient values, preferences and expectations for the treatment of recurrent ovarian cancer. Gynecol Oncol. 2017;146(2):392\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.039.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6767_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1748-5908-4-75","volume":"4","author":"G Elwyn","year":"2009","unstructured":"Elwyn G, Frosch D, Rollnick S. Dual equipoise shared decision making: definitions for decision and behaviour support interventions. Implement Sci. 2009;4(1):75. https:\/\/doi.org\/10.1186\/1748-5908-4-75.","journal-title":"Implement Sci"},{"key":"6767_CR25","doi-asserted-by":"crossref","unstructured":"Woolf S, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limiation, and harms of clinical guidelines. BMJ. 1999;318(7128):527\u201330.","DOI":"10.1136\/bmj.318.7182.527"},{"issue":"4","key":"6767_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/01.ede.0000165392.35273.d4","volume":"16","author":"ME Ossewaarde","year":"2005","unstructured":"Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, van der Graaf Y, Grobbee DE, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16(4):556\u201362. https:\/\/doi.org\/10.1097\/01.ede.0000165392.35273.d4.","journal-title":"Epidemiology."},{"issue":"5","key":"6767_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/13697130902780846","volume":"12","author":"A Benshushan","year":"2009","unstructured":"Benshushan A, Rojansky N, Chaviv M, Arbel-Alon S, Benmeir A, Imbar T, et al. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric. 2009;12(5):404\u20139. https:\/\/doi.org\/10.1080\/13697130902780846.","journal-title":"Climacteric."},{"key":"6767_CR28","first-page":"CD012858","volume":"8","author":"LAM van Lieshout","year":"2019","unstructured":"van Lieshout LAM, Steenbeek MP, De Hullu JA, Vos MC, Houterman S, Wilkinson J, et al. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. Cochrane Database Syst Rev. 2019;8:CD012858.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6767_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13063-018-3083-8","volume":"20","author":"A Idahl","year":"2019","unstructured":"Idahl A, Darelius A, Sundfeldt K, Palsson M, Strandell A. Hysterectomy and opportunistic salpingectomy (HOPPSA): study protocol for a register-based randomized controlled trial. Trials. 2019;20(1):10. https:\/\/doi.org\/10.1186\/s13063-018-3083-8.","journal-title":"Trials."},{"issue":"5","key":"6767_CR30","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00192-017-3418-0","volume":"29","author":"G Lamblin","year":"2018","unstructured":"Lamblin G, Meysonnier C, Moret S, Nadaud B, Mellier G, Chene G. Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition. Int Urogynecol J. 2018;29(5):715\u201321. https:\/\/doi.org\/10.1007\/s00192-017-3418-0.","journal-title":"Int Urogynecol J"},{"key":"6767_CR31","first-page":"CD003677","volume":"8","author":"JW Aarts","year":"2015","unstructured":"Aarts JW, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BW, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;8:CD003677.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"6767_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jogc.2016.04.084","volume":"38","author":"JN McAlpine","year":"2016","unstructured":"McAlpine JN, Tone AA, Hanley GE. Opportunistic salpingectomy: we chose to act, not wait. J Obstet Gynaecol Can. 2016;38(5):425\u20137. https:\/\/doi.org\/10.1016\/j.jogc.2016.04.084.","journal-title":"J Obstet Gynaecol Can"},{"issue":"1","key":"6767_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/07357907.2016.1242597","volume":"35","author":"NL Jones","year":"2017","unstructured":"Jones NL, Schulkin J, Urban RR, Wright JD, Burke WM, Hou JY, et al. Physicians' perspectives and practice patterns toward opportunistic salpingectomy in high- and low-risk women. Cancer Investig. 2017;35(1):51\u201361. https:\/\/doi.org\/10.1080\/07357907.2016.1242597.","journal-title":"Cancer Investig"},{"issue":"2","key":"6767_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","volume":"125","author":"JS Kwon","year":"2015","unstructured":"Kwon JS, McAlpine JN, Hanley GE, Finlayson SJ, Cohen T, Miller DM, et al. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy. Obstet Gynecol. 2015;125(2):338\u201345. https:\/\/doi.org\/10.1097\/AOG.0000000000000630.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6767_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ygyno.2017.05.034","volume":"146","author":"SE Dilley","year":"2017","unstructured":"Dilley SE, Havrilesky LJ, Bakkum-Gamez J, Cohn DE, Michael Straughn J Jr, Caughey AB, et al. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Gynecol Oncol. 2017;146(2):373\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.034.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"6767_CR36","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/IGC.0000000000001288","volume":"28","author":"B Lander","year":"2018","unstructured":"Lander B, Wilcox E, McAlpine JN, Finlayson SJ, Huntsman DG, Miller D, et al. Changing clinical practice: evaluation of implementing recommendations for opportunistic salpingectomy in British Columbia and Ontario. Int J Gynecol Cancer. 2018;28(6):1101\u20137. https:\/\/doi.org\/10.1097\/IGC.0000000000001288.","journal-title":"Int J Gynecol Cancer"},{"issue":"7565","key":"6767_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","volume":"333","author":"G Elwyn","year":"2006","unstructured":"Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417\u20130. https:\/\/doi.org\/10.1136\/bmj.38926.629329.AE.","journal-title":"BMJ."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-021-06767-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-06767-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T19:05:56Z","timestamp":1627153556000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-021-06767-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6767"],"URL":"https:\/\/doi.org\/10.1186\/s12913-021-06767-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,25]]},"assertion":[{"value":"26 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the Medical Ethical Committee \u2018CMO Regio Arnhem-Nijmegen\u2019 (2018\u20134978). Given the low impact of participation and participants not being subject to obligatory behaviors, this study was exempt from the Medical Research Involving Human Subjects Act (Dutch: WMO). This study was conducted in accordance with the guideline of Good Clinical Practice. All participants provided written consent and confirmed verbal consent before the interviews.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any identifiable data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"736"}}